Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 111, Issue 7, 3859-3862, April 1, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse
Blood Sportoletti et al. 111: 3859

Supplemental materials for: Sportoletti et al

Files in this Data Supplement:

  • Figure S1. Additional features of Npm1+/− mice hematological malignancies (JPG, 822 KB) -
    (A) Npm1+/− enlarged spleen is compared to a wild-type littermate control. (B) 10× (left panel, arrows) and 40× (right panel) magnification of perisinusoidal infiltrates in a representative Npm1+/− mouse liver composed of atypical mononuclear cells. (C) 10× (upper panel, arrow heads) and 40× (lower panel) magnification of a perirenal atypical mononuclear infiltrate. (D) Peri-intestinal tumor mass composed of atypical mononuclear infiltrate (upper panel 10×, lower panel 40× magnification). (E) 10× magnification of atypical lymphoid infiltrate replacing splenic architecture. The infiltrate is positive for CD20 (inset, 40× magnification) supporting involvement by a B-cell lymphoma. (F) Liver parenchyma (10× magnification) partially replaced by an atypical lymphoid infiltrate (arrow heads). (G) 10× magnification of atypical lymphoid infiltrate of spleen. The infiltrate is positive for CD3 (inset, 40× magnification) supporting involvement by a T-cell lymphoma.





  • Figure S2. Npm1 expression levels and genomic instability in Npm1+/− mice hematological malignancies (JPG, 437 KB) -
    (A) Hematoxylin and eosin (H&E) staining (upper panels) and immunohistochemical analysis of Npm1 expression (lower panels) in spleen sections from ML affected mice (middle and right panels) compared to a Npm1+/+ mouse as control (left panels). The insets show normal nuclear localization of Npm1. (B) Centrosome amplification in MPD-like ML cells. Representative bone marrow cytospins from Npm1+/− mouse without tumors and Npm1+/− mouse affected with MPD-like ML stained with an anti--tubulin (red) and DAPI (blue) are shown. White arrows point centrosomes. (C) Chromosomal abnormalities detected using CGH array analysis on haematological malignancies of six Npm1+/− mice. Chromosome gains and losses are listed as numerical abnormalities. The presence of structural abnormalities, such as deletion and duplication of chromosome regions, is indicated for each mouse.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020